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 99mTc-glutation (99mTc-GSH) radiopharmaceutical is available in the GSH 
lyophilized-kit in which ready to use directly after adding 99mTc radionuclide. In 
nuclear medicine, 99mTc-GSH diagnostic kit is a radiopharmaceutical commonly 
utilized for cancer diagnoses using imaging method. This paper described the 
physicochemical and biological characteristics as well as the quality of 99mTc-GSH
diagnostic kit prepared from the GSH lyophilized-kit. The radiochemical purity was 
determined with thin layer chromatography (TLC) method, performed on a TLC-SG 
stationary phase with a mobile phase of a dried acetone and 0,9% of NaCl solution. 
Studies on the effect of volume and radioactivity of Na99mTcO4 solution to the 
radiochemical purity of 99mTc-GSH were carried out. The sterility of GSH-
lyophilized kit and toxicity of 99mTc-GSH were also investigated. The stability test 
on GSH lyophilized kit and 99mTc-GSH in several storage conditions, as well as the 
plasma stability of 99mTc-GSH was performed. The analysis result showed that the 
GSH lyophilized-kit was sterile; the 99mTc-GSH was non toxic with 99.54 ± 0.01% 
of radiochemical purity and remained stable 5 hours either at room temperature or 4 
oC. The volume more than 4 mL of Na99mTcO4 solution on the labeling of GSH 
could decreased the 99mTc-GSH radiochemical purity, while the radioactivity more 
than 20 mCi in 7 mL of volume extended the incubation time. In-vitro stability test 
of 99mTc-GSH in plasma showed that in the two hours of storage, the radiochemical 
purity decreased to 51.84 ± 2.52%, and until 5 hours of storage it did not change 
significantly. From the result, it can be concluded that the GSH lyophilized-kit was 
remained stable after 13 month of storage either at room temperature or at 4 oC with 
99% of 99mTc-GSH radiochemical purity.  
 
© 2013 Atom Indonesia. All rights reserved
 
INTRODUCTION∗ 
 
In Indonesia, cancer is the third leading cause 
of death after heart disease and infections [1]. 
Therefore, early detection is very important to 
enable early stage treatments which are relatively 
easier than late stage treatments. Nuclear medicine 
plays an important role in early-stage cancer 
detection. Since 2009, BATAN-Bandung has 
conducted research to develop a 99mTc-glutathione 
(99mTc-GSH) radiopharmaceutical which is expected 
to be used as a diagnostic kit for early detection of 
cancer [2] in nuclear medicine. 
Glutathione with sulfhydryl groups (-SH)                     
on cysteinyl will react with 99mTc, formed complex 
containing tetravalent or pentavalent technetium 
coordinated with two thiol and nitrogen atoms                    
of two GSH ligand and an apical oxo group [3].                
This radiopharmaceutical is selected for the 
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diagnosis of cancer, particularly head and neck 
cancer [2]. 
99mTc-GSH is a chelate complex with the 
radionuclide 99mTc as the central atom [4,5].               
The radiopharmaceutical cold kits are available in 
the form of either dry or liquid kits which will be 
ready for use after reconstitution with 99mTc-
pertechnetate. 
Two of the conditions which must be met by 
a radiopharmaceutical diagnostic kit are as follows. 
First, the radiopharmaceutical should accumulate at 
the target organ for an optimal duration for imaging 
using gamma camera. Second, its properties must 
not be changed by the labeling process with the 
99mTc radionuclide. To ensure those conditions, the 
radiopharmaceutical must meet the quality 
requirement. 
Analysis of radiochemical purity of the 
radiopharmaceutical is necessary to ensure that it 
has a high purity. Therefore, it will accumulate 
mainly in target organs and only minimally 
accumulates in unintended organs. This paper 
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describes the physicochemical and biological 
evaluation of the lyophilized GSH kit producd            
here, which includes the following evaluations:            
(1) evaluation of the effects of the volume of 
sodium pertechnetate which is added to the 
lyophilized GSH kit; (2) evaluation of the effects of 
the radioactivity of the sodium pertechnetate;               
(3) analysis of the radiochemical purity of                
99mTc-GSH; (4) determination of the plasmatic 
stability of 99mTc-GSH in vitro; (5) analysis of the 
stability of 99mTc-GSH and lyophilized GSH kit in a 
variety of storage conditions; (6) toxicity test of 
99mTc-GSH in animals; and (7) sterility test of 
lyophilized GSH kit. 
The physicochemical and biological 
characteristics and quality data of 99mTc-glutathione 
obtained in this research are useful for supporting 
the utilization of 99mTc-GSH for cancer diagnosis. 
 
 
EXPERIMENTAL METHODS 
 
The materials used include: L-reduced 
glutathione (GSH) produced by Aldrich; Na99mTcO4 
solution obtained using 99Mo-99mTc generator 
produced by Batan Technology; aqua bidest 
(double-distilled water) and NaCl physiological 
solution for sterile injection produced by IPHA 
Laboratories; SnCl2·2H2O, acetone, sodium 
hydroxide, hydrochloric acid and other reagents of 
analytical grade from E. Merck; thin-layer 
chromatography silica gel (TLC-SG) plates from          
E. Merck; and disposable syringe (sizes 1, 2.5,                
5 mL) from Terumo. Test animals used were 3-3,5 
months old white mice of the Swiss Webster strain. 
The equipment were used include          
Mettler-Toledo analytical balances, a Victoreen 
dose calibrator from Victoreen, a Retsch                 
vortex mixer, a Memmert oven, a Denver 
Instrument pH-meter, a Schlumberger single-
channel Analyzer, a Labconco freeze-dryer, laminar 
air flow, a Heraeus incubator, and a set of tools                 
for ascending chromatography. 
The rest of this section details the                      
steps followed in this work. The steps are                     
as follows. 
 
 
Preparation of glutathione (GSH) dry kit 
radiopharmaceutical 
 
The preparation of dry kit was done using 
lyophilization, also known as freeze-drying. Vials 
containing 20 mg of GSH and 0,3 mg SnCl2.2H2O 
with initial volumes of 1,3 mL and pH of 7-7,5 were 
prepared [6]. Sterilization was done by filtering the 
solution using bacterial filter (0.22 µm), into sterile 
vials and then lyophilized for 24 hours in a freeze-
dryer. The lyophilized kits were then vacuum-tested 
manually and their dryness was observed visually. 
 
 
Sterility test for lyophilized GSH kit  
 
The sterility of the lyophilized GSH kits was 
determined by the method described in 
Pharmacopoeia Indonesia [7]. In this test, two kinds 
of media, liquid thioglycolate and nutrient agar, 
were used, and the test was conducted aseptically 
under a laminar air flow (LAF). 
The lyophilized GSH kit was reconstituted 
with 1 mL of sterile physiological saline (0.9%) 
solution, and then shaken until homogeneous. The 
radiopharmaceutical was then smeared into the 
surface of each medium using needle loops. Then, 
the media was placed in an incubator with a 
temperature of 37°C and was monitored for               
7-14 days for the possibility  of the growth of 
bacteria or mold. 
 
 
Preparation of radiopharmaceutical  
99mTc-GSH 
 
99mTc-GSH radiopharmaceutical was obtained 
by adding 2 mL Na99mTcO4 (≈ 10-20 mCi) into the 
lyophilized GSH kit. The kit was then shaken until 
homogeneous. The resulting preparation was then 
ready for analysis. 
 
 
Radiochemical purity determination of 
99mTc-GSH 
 
The radiochemical purity of 99mTc-GSH was 
determined by ascending thin-layer chromatography 
method using 1×10 cm TLC-SG as the stationary 
phase. The TLC-SG plates were marked at each one 
cm from -1 to 8 as the stationary phase. As the 
mobile phase, two kinds of solvents were used, i.e, 
dried acetone and physiological saline solution 
(0,9%) [6]. 99mTc-GSH solution was spotted on a 
TLC-SG at zero point and elution was carried up to 
the limit at mark 8. Chromatograms were dried in 
the oven, wrapped in tape to avoid the release of 
powdered silica gel, then cut into 1 cm long pieces, 
and each piece was counted using a single channel 
counter with NaI(Tl) detector. 
 
 
Stability test of the lyophilized GSH kits 
 
Lyophilized GSH kits were treated in two 
different storage conditions, at room temperature of 
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25 ± 1°C and at of 4 ± 1°C. The stability test of the 
lyophilized GSH kit was conducted every month by 
determining the radiochemical purity after labeling 
the kit with 10-20 mCi/ml of 99mTc. 
 
 
Toxicity testing of 99mTc-GSH 
 
The toxicity test of 99mTc-GSH was 
performed using the methods described in the 
Pharmacopoeia Indonesia [7]. Large doses of               
100 times human doses per unit body weight were 
used in this eperiment [8]. Based on the 
calculations, 0.5 mL of 99mTc-GSH with an activity 
of 860 µCi was injected intravenously to each of 
five mice. The mice were 3 to 3,5 months of age. 
They were then observed for 48 hours after 
injection. If the mice stay alive after 48 hours and 
show no toxicity symptoms, it would indicate the 
absence of toxicity effects from 99mTc-GSH.  
 
 
The influence of Na99mTcO4 solution volume 
to the radiochemical purity of 99mTc-GSH 
 
The test was performed by addition of varying 
volumes (1, 2, 4, 6, 7, 8, and 10 mL) of Na99mTcO4 
solution of a constant activity (≈ 10 mCi) into 
lyophilized GSH kits. After shaken for brief time, the 
radiochemical purity was determined by thin layer 
chromatography method. 
 
 
The influence of the radioactivity Na99mTcO4 
to the radiochemical purity of 99mTc-GSH 
 
A fixed volume of 2 mL of Na99mTcO4 with 
varying activities (5, 10, 20, 30 and 40 mCi) was 
added into lyophilized GSH kits. After shaken for a 
few moments, the radiochemical purity was 
determined at 0, ½, 1, 2, 3, 4 and 5 hours with 
chromatographic methods. 
Afterward, the above test was repeated with a 
larger volume (7 mL) of Na99mTcO4, also with 
varying activities (10, 20, 30, 40, 50 and 70 mCi). 
The resulting data is needed to determine whether 
the radiopharmaceutical could be used in multi-dose 
or single dose. 
 
 
99mTc-GSH stability on storage 
 
The stability of 99mTc-GSH after labeling was 
tested at two different temperatures, temperature of 
25 ± 1°C and at of 4 ± 1°C. The radiochemical 
purity was observed at certain times (0, ½, 1, 2, 3, 4 
and 5 hours). Determination of radiochemical purity 
was conducted by thin layer chromatography. 
Plasmatic stability of 99mTc-GSH  
 
The stability of 99mTc-GSH in human blood 
plasma was determined by adding 250 µL of            
99mTc-GSH to vials containing 750 µL of human 
blood plasma (human plasma). The plasma was then 
stirred with a vortex mixer and placed in a 37°C 
incubator. After mixing, radiochemical purity was 
determined at certain times (½, 1, 2, 3, 4 and               
5 hours) with TLC method. For comparison, the 
stability test was also done using phosphate buffer 
instead of blood plasma. 
 
 
RESULTS AND DISCUSSION 
 
The 99mTc-GSH radiopharmaceutical for the 
diagnosis of cancer was made in kit form, based on 
a formula derived in a previous study [6].              
However, it must be noted here that the lyophilized 
GSH kit itself does not contain any radioactive 
substance. Therefore, it has to be mixed with 
Na99mTcO4 solution to provide the 99mTc-GSH 
radiopharmaceutical. It is mandatory to perform 
physicochemical and biological analysis to ensure 
that the lyophilized GSH kits meet the quality 
requirements and are fit for clinical uses. 
Visual observation showed that the 
lyophilized GSH kit was in the form of an odorless 
white solid which resembled cotton. 99mTc-GSH 
must be free of microorganisms such as bacteria or 
fungi which can cause infections to patients.               
To obtain sterile 99mTc-GSH, both the GSH dry kit 
and the 99mTc must be sterile, and the addition of 
99mTc to the kit has to be performed aseptically.            
In the sterility testing, the addition process was 
performed in a Laminar Air Flow (LAF) cabinet. 
Solid nutrient agar was used to determine the 
presence of bacteria, while thioglycolate liquid 
medium was used to detect fungi. The sterility 
testing was performed with three repetitions of the 
GSH dry kits drawn at random. Visually, the tests 
showed no growths, both of bacteria and fungi, in 
any media after a seven-day incubation period.           
This means that the GSH dry kits were sterile. 
The average of radiochemical purity of               
15 99mTc-GSH replicates was 99.54 ± 0.01%, with 
very low radiochemical impurities, in the form of 
free pertechnetate (99mTcO4-) and reduced-99mTc 
(99mTcO2) were 0.116 + 0.01% and 0.30 + 0.01% 
respectively. The radiochemical purity of 99mTc-
GSH obtained from this experiment, shown in              
Fig. 1, are similar to the values obtained in previous 
studies, with a radiochemical purity of greater than 
95% [6]. The radiochemical purity of 99mTc-GSH 
found in this study meets the requirements for the 
radiopharmaceutical, which is ≥ 90% [9], and shows 
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good reproducibility, as seen from the small 
standard deviation. 
 
 
 
Fig. 1. Radiochemical purity of 99mTc-GSH made from                
Lyophilized GSH kit. 
 
The GSH kits prepared in a freeze-dried form 
(lyophilized kit) have a long shelf life, ranging from 
several months to years [10]. The expiration time of 
dried kits had to be determined to allow testing of 
the stability of the storage time. The expiration date 
of dried GSH kits can be determined by testing the 
radiochemical purity every month after labeled with 
99mTc. After storage for 13 months, either at               
room temperature or 4°C, 99mTc-GSH still has 
radiochemical purity greater than 99% (Fig. 2).                 
It can be stated that the dry GSH kit remained stable 
and still met the requirement of radiochemical 
purity being no less than 90% [5,9]. 
 
 
 
 
Fig. 2. Stability of Lyophilized GSH kit. 
 
The results of the toxicity testing of          
99mTc-GSH with five white mice are shown in     
Table 1. They indicate that no mice died or 
exhibited abnormalities within the observation period 
of 24 hours to seven days. It means that 99mTc-GSH is 
not toxic; thus, we continued to the next test. 
Table 1. Abnormality conditions of test animals after 99mTc-
GSH injection. 
 
 
Mice 
Day 
1 2 3 4 5 6 7 
1 - - - - - - - 
2 - - - - - - -
3 - - - - - - - 
4 - - - - - - - 
5 - - - - - - - 
 
Description: (-) animals remain life and showed no symptoms of 
abnormality. 
 
In the labeling of lyophilized kit with 
radionuclide 99mTc, to achieve the desired activity, 
sometimes a large volume of Na99mTcO4 solution is 
required. Therefore, in this research, the influence of 
the volume and activity of Na99mTcO4 solution               
to the radiochemical purity of 99mTc-GSH was 
investigated. The results are presented in Fig. 3, 
which shows that the use of 1-4 mL of Na99mTcO4 
solution resulted in radiochemical purity of               
99mTc-GSH exceeding 99%. Radiochemical purity 
decreased to 97% when the volume of Na99mTcO4 
solution was increased 10 mL. Increasing the 
volume decreases reaction rate [11], and therefore 
not all of the existing 99mTcO4- in the solution was 
reduced to form 99mTcO2 or 99mTc-reduced and 
bound to GSH to form 99mTc-GSH. Nevertheless, 
the radiochemical purity of 99mTc-GSH still 
exceeded 90% which qualifies it as a good 
radiopharmaceutical [12]. 
 
 
Fig. 3. Effect of volume Na99mTcO4 used in the labeling of 
Lyophilized GSH kit to the radiochemical purity of 99mTc-GSH.  
 
The investigation of the influence of activity 
was conducted using a fixed volume of 7 mL of 
Na99mTcO4 with activities of 10, 20, 30, 40, 50 and 
70 mCi. Table 2 shows that at the incubation time of 
0 minutes, under activities of 10 and 20 mCi, the 
radiochemical purity greater was than 90%, while 
for 30, 40, 50 and 70 mCi, radiochemical purity was 
low, amounting to 54.58 ± 0.68%, 47.87 ± 0.77%, 
33.83 ± 0.81% and 20.68 ± 0.78% respectively. 
When the incubation time was extended to               
30 minutes, the radiochemical purity of 99mTc-GSH 
increased to more than 90%, except for the activity 
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of 70 mCi, in which a longer incubation time, up to 
3 hours, was required. The results also show                    
that after the addition of Na99mTcO4 with increased 
radioactivity, after a brief shaking (incubation             
time 0 minutes), the radiochemical impurities of 
99mTcO4- increased. This means that there is              
still much 99mTc (VII), which has not been reduced 
by the reductant Sn (II) to 99mTc-reduced form 
which binds to glutathione (GSH) to form                    
99mTc-GSH [5,6]. 
 
Table 2. The percentage of radiochemical impurities 99mTcO4-
and 99mTcO2 contained in 99mTc-GSH with the influence of 
Na99mTcO4 radioactivity in labeling of lyophilized kit GSH. 
 
Time 
(hour) 
Activity (mCi) 
10 20 30 40 50 70 
0 
A 1.45 2.61 45.07 51.89 65.96 79.07 
B 0.09 0.36 0.39 0.24 0.21 0.25 
½ 
A 0.10 0.08 0.32 0.64 7.26 55.41 
B 0.01 0.08 0.15 0.40 0.28 0.39 
1 
A 0.11 0.16 0.23 0.41 0.57 37.52 
B 0.10 0.22 0.18 0.30 0.52 0.32 
2 
A 0.06 0.17 0.34 0.15 3.08 15.00 
B 0.13 0.11 0.17 0.19 0.21 0.40 
3 
A 0.10 0.10 0.81 0.48 0.49 0.40 
B 0.08 0.25 0.93 0.40 0.30 0.30 
4 
A 0.04 0.19 0.25 0.30 1.93 0.28 
B 0.21 0.40 0.20 0.30 0.27 0.28 
5 
A 0.07 0.16 0.55 0.70 2.63 0.54 
B 0.05 0.20 0.42 0.25 0.25 0.27 
 
Description: 
A : 99mTcO4- (%) 
B : 99mTcO2 (%) 
 
Figure 4 shows the comparison of pattern 
formation on 99mTc-labeling dry kit GSH                      
with Na99mTcO4 in 2 and 7 mL of volume.                      
The results showed that with the same incubation 
time, the radiochemical purity of 99mTc-GSH                
with 7 mL volume was lower (97.04 ± 1.50%) 
compared with 99mTc-GSH with 2 mL                      
volume (99.39 ± 0.57%). When the incubation                 
time was extended to 30 minutes, the radiochemical 
purities of both radiopharmaceuticals exceed                 
99% and are stable for the five hour incubation              
time. These results showed that the formation                
rate of 99mTc-GSH was only weakly influenced by 
the volume. 
 
 
Fig. 4. Comparison of 99mTc-GSH formation patterns in 
labeling of Lyophilized GSH kit using Na99mTcO4 with different 
volume and radioactivity (≈ 20 mCi). 
 
The stability of the 99mTc-GSH diagnostic               
kit could be obtained by observing the 
radiochemical purity for a specific duration.               
The results showed that when stored at room 
temperature for up to five hours, the 
radiopharmaceutical maintains a radiochemical 
purity above 99%, as shown in Fig. 5.               
From this analysis it can be stated that 99mTc-GSH 
with activity in the 5 to 40 mCi range, when               
stored at room temperature, can still be used               
up to five hours after the addition of the 99mTc. 
 
 
Fig. 5. Stability of 99mTc-GSH diagnostic kits made from the 
Lyophilized GSH kit in various concentrations of radioactivity. 
 
The stability of 99mTc-GSH in plasma is 
presented in Fig. 6. It shows that the radiochemical 
purity of 99mTc-GSH in plasma decreased rapidly. 
After storage for 2 hours, radiochemical purity of 
99mTc-GSH was 51.84 ± 2.52%, while after 3,4 and               
5 hours, radiochemical purity did not significantly 
change further; they were 47.43 ± 0.08%,               
46.99 ± 1.44% and 44.87 ± 4.39%, respectively. 
This result indicates that 99mTc-GSH has a low 
stability in plasma. In contrast, when 99mTc-GSH  
was stored in phosphate buffer for up to 3 hours, its 
radiochemical still exceeded 90% (91.24 ± 4.39%). 
95
96
97
98
99
100
0 2 4 6
R
ad
io
ch
em
ic
al
 p
ur
ity
 o
f  
99
m
Tc
-G
SH
 (%
)
time (hours)
2 mL 7 mL
95
96
97
98
99
100
0 1 2 3 4 5 6
R
ad
io
ch
em
ic
al
 p
ur
ity
 o
f
99
m
Tc
-G
SH
 (%
)
time (hours)
5 mCi 10 mCi 20 mCi 30 mCi 40 mCi
M. E. Sriyani, N.  Zainuddin  / Atom Indonesia Vol. 39  No. 2  (2013) 82 - 87 
 
 
Fig. 6. Stability of 99mTc-GSH made from lyophilized GSH kit 
in a variety of storage conditions. 
 
 
CONCLUSION 
 
Dry kits of GSH have been produced by 
lyophilization. The kits are in the form of an 
odorless white solid which resembles cotton and are 
packaged in sterile vials under vacuum conditions. 
They are stable for 13 months of storage at room 
temperature and at 4oC. 
99mTc-GSH which was obtained from the 
lyophilized GSH kit has a radiochemical purity of 
99.54 ± 0.01%, is non-toxic and stable for up to                
5 hours of storage at room temperature and at 4oC. 
The stability of 99mTc-GSH in blood plasma is less 
than those stored at room temperature and at 4°C; 
within two hours, the radiochemical purity 
decreases to 51.84 ± 2.52%. 
For volumes of Na99mTcO4 exceeding 4 mL 
the radiochemical purity of 99mTc-GSH decreases. 
Further, the use of 99mTc with an activity greater 
than 20 mCi with a large volume (7 mL) results in 
the extension of the required incubation time to 
attain radiochemical purity ≥ 90%. 
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